Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients

Julie R. Brahmer, Georgina V. Long, Omid Hamid, Edward B. Garon, Roy S. Herbst, Thierry André, Philippe Armand, Dean F. Bajorin, Joaquim Bellmunt, Barbara Burtness, Toni K. Choueiri, Ezra E.W. Cohen, Luis A. Díaz, Kohei Shitara, Girish S. Kulkarni, David F. McDermott, Manish A. Shah, Josep Tabernero, Arndt Vogel, Pier Luigi Zinzani, Niusha Jafari, Steven Bird, Ellen Snyder, Christine K. Gause, Oswaldo L. Bracco, M. Catherine Pietanza, Todd Gruber, Antoni Ribas